Indoco Remedies has received Establishment Inspection Report (EIR) from USFDA approving the company’s sterile manufacturing facility (Plant II) and solid dosage manufacturing facility (Plant III) located in Verna, Goa. Last year in August, the USFDA had carried out inspection in the said plant.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.